Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 28, 2014 08:46 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Announces Signing of Final Settlement and License Agreement With Neptune

MIGDAL HA'EMEQ, Israel, April 28, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid...
April 28, 2014 08:00 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. to Report First Quarter Fiscal Year 2014 Financial Results

MIGDAL HA'EMEQ, Israel, April 28, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that it will...
April 21, 2014 08:00 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Announces a Final Decision Issued by the USPTO Rejecting All the Claims in Neptune's Patent

MIGDAL HA'EMEQ, Israel, April 21, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid...
April 01, 2014 08:00 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Provides Update on Patent Litigation With Neptune

MIGDAL HA'EMEQ, Israel, April 1, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid...
March 05, 2014 16:05 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Announces Closing of Upsized Secondary Public Offering, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

MIGDAL HA'EMEQ, Israel, March 5, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company") today announced the closing of a registered public offering by certain selling shareholders of...
February 27, 2014 21:00 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Announces Pricing of Secondary Offering

MIGDAL HA'EMEQ, Israel, Feb. 27, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company") today announced the pricing of a registered secondary public offering. The size of the offering...
February 13, 2014 06:23 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Files Registration Statement for Proposed Secondary Offering

MIGDAL HA'EMEQ, Israel, Feb. 13, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company") today announced that it has filed a registration statement on Form F-1 with the Securities and...
February 13, 2014 06:00 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Reports Fourth Quarter and Full Year 2013 Unaudited Financial Results

Quarterly Net Revenues Increased 59% to $18.5 Million and Annual Net Revenues Increased 72% to $65.0 Million Quarterly Net Income Increased 57% to $3.4 Million, or $0.15 Per Share, and Annual Net...
February 06, 2014 16:05 ET | Source: Enzymotec Ltd.

Photo Release -- Enzymotec Ltd. Awarded the Title of Outstanding Exporter for 2012

MIGDAL HA'EMEQ, Israel, Feb. 6, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today that it...
February 04, 2014 08:24 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. to Report Fourth Quarter and Fiscal Year 2013 Financial Results

MIGDAL HA'EMEQ, Israel, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that it will...